Immune-Onc Therapeutics, Inc. Partnership

Core members and collaborators publish on innovations in antibody-drug conjugates

AlaMab Therapeutics, Inc. licensing deals

The An group’s antibody proteinase hinge cleavage work was discussed in an article of Genetic Engineering & Biotechnology News (GEN)

Dr. An organized a special issue on therapeutic antibodies for the journal Protein and Cell: “Magic Bullets” at the center stage of immune therapy

Dr. An was featured in an article of the HealthLEADER, which provides information about health from resources at the UT Health Houston

Cell Reports article was published with results of the EGFL6 project for specifically blocking ovarian tumor angiogenesis

The Annual Symposium of the CPRIT Therapeutic Antibody Core – 2017

$6 million in grants from the U.S. Department of Defense


The Annual Symposium of the CPRIT Therapeutic Antibody Core – 2016

The Many Faces of UTHealth


Dr. An awarded a $900,000 CPRIT grant to further investigate how tumors evade therapeutic antibodies

Establishment of the Therapeutic Antibody Core

Dr. An achieves prestigious award from the Society for Industrial Microbiology and Biotechnology (SIMB)